Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says

Pfizer (PFE) CEO Albert Bourla is betting big on repeating the success of its COVID-19 vaccine with an experimental oral treatment — and he's putting the company's money where its mouth is.